ArticleInflammation2014
AS252424, a PI3Kγ inhibitor, downregulates inflammatory responsiveness in mouse bone marrow-derived mast cells.
Article in Inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 11 citations in OpenAlex.
- Vasicine Attenuates Allergic Asthma by Suppressing Mast Cell Degranulation and Th2 Inflammation via Modulation of the FcεRI/Lyn + Syk/MAPK Pathway.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases.Science advances · 2024Article
- Discovery of a novel phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor against hematologic malignancies and theoretical studies on its PI3Kγ-specific binding mechanisms.RSC advances · 2019Article
- Inhibition of theThe Journal of pharmacology and experimental therapeutics · 2018Article
- Inhibitory Effects of JEUD-38, a New Sesquiterpene Lactone from Inula japonica Thunb, on LPS-Induced iNOS Expression in RAW264.7 Cells.Inflammation · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PI3Kγ is known to play an important role in inflammation and immune responses. Mast cells are closely involved in the initiation and regulation of immune responses and allergic inflammatory reactions. AS252424 is a specific PI3Kγ inhibitor. Until now, the anti-inflammatory effect of AS252424 on mast cells has not been reported. In this study, we investigated the anti-inflammatory effects of AS252424 on the inflammatory mediators in activated bone marrow-derived mast cells (BMMCs). AS252424 dramatically attenuated c-Kit ligand (KL)-induced leukotriene C4 (LTC4) generation and degranulation in BMMCs. Downregulating phosphorylation of cytosolic phospholipase A2 (cPLA2) and mitogen-activated protein kinase (MAPK) and inhibition of Ca(2+) liberation in BMMCs might be involved in the anti-inflammatory effects. These results suggested that AS252424 might be considered as a chemical tool or a drug candidate for prevention and therapy of inflammatory disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.